Publikation: The European Human Biomonitoring Initiative
dc.contributor.other | Kolossa-Gehring, Marike | |
dc.contributor.other | Ganzleben, Catherine | |
dc.contributor.other | Doyle, Ulrike | |
dc.contributor.other | Lange, Rosa | |
dc.contributor.other | Pack, Kim Laura | |
dc.contributor.other | Reiber, Lena | |
dc.contributor.other | Fiddicke, Ulrike | |
dc.contributor.other | Conrad, André | |
dc.date.issued | 2016 | |
dc.description.abstract | The proposal for a European Human Biomonitoring initiative was developed by a consortium of representatives from 26 countries, with input from the European Environment Agency, in response to a Horizon 2020 call, under the Work Programme on Health, demographics changes and well-being. The proposal was submitted in April 2016 and, if accepted, the initiative will launch early 2017. This presentation will outline the objectives and strategy of the initiative. The overarching goal of the initiative is to generate knowledge to inform the safe management of chemicals and so protect human health in Europe. We will use human biomonitoring to understand human exposure to chemicals and resulting health impacts and will communicate with policy makers to ensure that our results are exploited in the design of new chemicals policies and the evaluation of existing measures. Key objectives include: - Harmonizing procedures for human biomonitoring across 26 countries, to provide policy makers with comparable data on human internal exposure to chemicals and mixtures of chemicals at EU level; - Linking data on internal exposure to chemicals to aggregate external exposure and identifying exposure pathways and upstream sources. Information on exposure pathways, including environmental, occupational, consumer and dietary exposure, is critical to the design of targeted policy measures to reduce exposure; - Generating scientific evidence on the causal links between human exposure to chemicals and negative health outcomes; and - Adapting chemical risk assessment methodologies to use human biomonitoring data and account for the contribution of multiple external exposure pathways to the total chemical body burden. We will achieve these objectives by harmonizing human biomonitoring initiatives in 26 countries, drawing on existing expertise and building new capacities. To this end, we will create a robust Human Biomonitoring Platform at European level, supported by National Hubs in each country. The National Hubs will consolidate expertise and experience at national level, feed priorities up to EU level, and coordinate activities between the national and EU level. The initiative will contribute directly to the improvement of health and well-being for all age groups, by investigating how exposure to chemicals affects the health of different groups, such as children, pregnant women, foetuses and workers. We will also investigate how factor such as behavior, lifestyle and socio-economic status influence internal exposure to chemicals across the EU population. This knowledge will support policy action at EU and national levels to reduce chemical exposure and protect health. In: Abstract Book / International Society of Exposure Science - Annual Meeting : interdisciplinary approaches for health and the environment ; Utrecht, the Netherlands, october 9-13. Utrecht: 2016, Seite 606-607 | en |
dc.format.extent | 1 Onlineressource (18 Vortragsfolien) | |
dc.format.medium | online resource | |
dc.identifier.uri | https://openumwelt.de/handle/123456789/7071 | |
dc.language.iso | eng | |
dc.rights.uri | http://rightsstatements.org/vocab/InC/1.0/ | |
dc.title | The European Human Biomonitoring Initiative | |
dc.type | Conference proceedings | |
dc.type | Monographie | |
dspace.entity.type | Publication | |
local.bibliographicCitation.conference | 26th Annual Meeting of the International Society of Exposure Science (26 : 2016 : Utrecht) | |
local.bibliographicCitation.publisherPlace | Utrecht | |
local.collection | Rede | |
local.subtitle | objectives and strategy |